Increased Risk of Preeclampsia with Assisted Reproductive Technologies.

Assisted reproductive technology Frozen embryo transfer Hypertensive disorders of pregnancy Preeclampsia Pregnancy complications

Journal

Current hypertension reports
ISSN: 1534-3111
Titre abrégé: Curr Hypertens Rep
Pays: United States
ID NLM: 100888982

Informations de publication

Date de publication:
09 2023
Historique:
accepted: 19 05 2023
medline: 11 9 2023
pubmed: 12 6 2023
entrez: 11 6 2023
Statut: ppublish

Résumé

We summarized recent available data to assess the association between assisted reproductive technology (ART) and risk for preeclampsia. The majority of clinical studies supporting the association of preeclampsia and ART are retrospective. Published data from both clinical and pre-clinical studies suggest specific ART procedures may contribute to the increased risk, including in vitro embryo handling and development, hormone stimulation, transfer cycle types, and use of donor oocytes/embryos. Potential mechanisms include epigenetic aberrations leading to abnormal placentation, absence of factors secreted by the corpus luteum, and immunologic responses to allogenic gametes. There is an increased risk of preeclampsia following ART. Treatment plans that favor reduced preeclampsia risk should be considered for ART pregnancies. To make ART pregnancies safer, additional clinical and animal model studies are needed to elucidate the underpinnings of this risk association.

Identifiants

pubmed: 37303020
doi: 10.1007/s11906-023-01250-8
pii: 10.1007/s11906-023-01250-8
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-261

Informations de copyright

© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Auteurs

Molly S Kornfield (MS)

Division of Reproductive Endocrinology & Infertility, Department of Obstetrics & Gynecology, Oregon Health & Science University, Portland, OR, USA.

Susan B Gurley (SB)

Division of Nephrology & Hypertension, Department of Medicine, Oregon Health & Science University, Portland, OR, USA.

Lisa A Vrooman (LA)

Division of Reproductive and Developmental Sciences, Oregon National Primate Research Center, Oregon Health & Science University, 505 NW 185th Ave, Beaverton, OR, USA. vrooman@ohsu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH